10 Stocks Under $5 with Huge Upside Potential

7. AbCellera Biologics Inc. (NASDAQ:ABCL)

AbCellera Biologics Inc. (NASDAQ:ABCL) is one of the best stocks under $5 with huge upside potential. On April 9, JonesResearch initiated coverage of AbCellera Biologics Inc. (NASDAQ:ABCL) with a Buy rating and set a $11 price target. The firm stated that the company’s validated antibody discovery platform has advanced 19 molecules into the clinic across internal and partnered programs spanning several indications, adding that AbCellera Biologics Inc.’s (NASDAQ:ABCL) capabilities are “best illustrated” by its collaboration with Eli Lilly.

In its financial results for the full year 2025, AbCellera Biologics Inc. (NASDAQ:ABCL) reported that it successfully delivered on all its corporate priorities while transitioning to a clinical-stage biotech company and ending the year with around $700 million in available liquidity to execute on its strategy. For the full year, AbCellera Biologics Inc. (NASDAQ:ABCL) earned $75.1 million in total revenue and generated a net loss of $146.4 million, compared to a net loss of $162.9 million in the prior year period.

AbCellera Biologics (NASDAQ:ABCL) solves antibody discovery problems by integrating data science, technology, infrastructure, and interdisciplinary teams. It develops and discovers antibody medicines for indications across therapeutic areas, including metabolic and endocrine conditions, cancer, and autoimmune disorders. It boasts technology platforms that unlock drug classes, modalities, and targets, including T-cell engagers, peptide-MHCs, and transmembrane proteins.